SmadMinX

TLDR

SmadMin-Therapeutics develops proprietary low molecular weight llama antibodies (VHH) for cancer prevention and metastasis reduction in gastro-intestinal cancer patients.

Overview

SmadMin-Therapeutics B.V. is a startup led by Prof. Dr. Sheila Krishnadath that owns novel therapeutics designed to prevent cancer recurrence. The company's molecules are low molecular weight llama antibodies with high specificity against growth factors critical in cancer cell replication and spread. Preclinical studies demonstrated potential effects in preventing lung and liver metastasis in aggressive cancer subtypes.